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Abstract
Background: Prenatal smoke exposure is known to be robustly associated with DNA
methylation among offspring in early life, but whether the association persists into adult-
hood is unclear. This study aimed to investigate the long-term effect of maternal smoke
exposure on DNA methylation in 754 women (mean age 30years); to replicate findings in
the same women 18years later and in a cohort of 230 men (mean age 53 years); and to
assess the extent to which a methylation score could predict prenatal smoke exposure.
Methods: We first carried out an epigenome-wide association analysis for prenatal
smoke exposure and performed replication analyses for the top CpG sites in the other
samples. We derived a DNA methylation score based on previously identified CpG sites
and generated receiver operating characteristic (ROC) curves to assess the performance
of these scores as predictors of prenatal smoke exposure.
Results:We observed associations at 15 CpG sites in 11 gene regions:MYO1G, FRMD4A,
CYP1A1, CNTNAP2, ARL4C, AHRR, TIFAB,MDM4, AX748264, DRD1, FTO (false discovery
rate<5%). Most of these associations were specific to exposure during pregnancy, were
present 18 years later and were replicated in a cohort of men. A DNA methylation score
could predict prenatal smoke exposure (30 years previously) with an area under the
curve of 0.72 (95% confidence interval 0.69, 0.76).
Conclusions: The results of this study provide robust evidence that maternal smoking in
pregnancy is associated with changes in DNA methylation that persist in the exposed off-
spring for many years after prenatal exposure.
Key words: prenatal smoking, ALSPAC, DNA methylation, epigenetics, long-term, prediction, epigenome-wide
association study, longitudinal
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Introduction
Cigarette smoke exposure during pregnancy is an environ-
mental stressor that has a profound effect on DNA methyl-
ation in the exposed offspring.1 Previous work has
determined genome-wide changes in DNA methylation in
response to smoke exposure in utero,2 with a recent
epigenome-wide association study (EWAS) meta-analysis
of methylation in newborn cord blood identifying over
6000 differentially methylated CpG sites (of which 568
CpG sites surpassed the strict Bonferroni threshold).3
It is of interest to investigate the persistence of methyla-
tion marks into later life, as this presents the opportunity
to use methylation as an archive of historical exposure,
particularly if methylation patterns can be robustly mod-
elled over time.4–6 In addition, persistent changes in DNA
methylation might mediate at least some of the associa-
tions between smoke exposure in pregnancy and later-life
health outcomes.7
Several studies have identified prenatal smoke exposure
associated changes in methylation in childhood and adoles-
cence in global methylation,8 candidate gene8–10 and
EWAS.3,4,6,11–13 However, few studies have investigated
the persistence of methylation change into adulthood.14–17
Three such studies have been conducted in the New York
City birth cohort, where prospectively assessed maternal
smoking during pregnancy was found to be positively asso-
ciated with global methylation in leukocytes of individuals
at age 43 years assessed using a methyl acceptance assay,14
inversely associated with levels of Sat2 methylation15 and
most recently associated with methylation at 17 CpG sites
on the Illumina Infinium HumanMethylation450 array,17
which remained even after adjustment for adult smoking
status of the offspring. However, previous studies were
limited by low power due to small sample sizes and a more
comprehensive assessment of the long-term impact of
prenatal tobacco smoke exposure on genome-wide methyl-
ation is warranted.
In this study, we aimed to assess the long-term impact
of prenatal tobacco smoke on DNA methylation in the
context of the Avon Longitudinal Study of Parents and
Children (ALSPAC)18,19—a prospective birth cohort with
data on reported maternal smoke exposure in pregnancy
and genome-wide DNA methylation levels of offspring in
adulthood. We first conducted an analysis to investigate
associations between reported prenatal smoke exposure
and DNA methylation in peripheral blood among women
in ALSPAC (mean age 30 years). We next attempted to rep-
licate prenatal smoking-associated DNA methylation dif-
ferences in peripheral blood of the women 18 years later
(mean age 48 years) and in men from the same study (the
partners of these women) (mean age 52 years). Finally, we
aimed to assess the extent to which a prenatal smoking
score, based on methylation at CpG sites previously shown
to be associated with prenatal smoke exposure, could pre-
dict whether the mothers of the ALSPAC women smoked
during pregnancy.
Methods
Cohort and selection of participants
ALSPAC is a large, prospective cohort study based in the
south-west of England. A total of 14 541 pregnant women
resident in Avon, UK, with expected dates of delivery 1
April 1991 to 31 December 1992 were recruited and de-
tailed information has been collected on these women and
their offspring at regular intervals.18,19 The study website
contains details of all the data that are available through a
fully searchable data dictionary (http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/). Written
informed consent has been obtained for all ALSPAC
Key Messages
• We investigated the long-term impact of maternal smoking in pregnancy on epigenetic changes in the offspring by
assessing differences in DNA methylation levels in adulthood.
• We observed associations at 15 CpG sites in 11 gene regions; most of these associations were specific to exposure
during pregnancy, were found to persist until at least 48 years and were present in both men and women.
• A prenatal smoking score, derived by combining methylation values, could adequately predict whether the mothers
of the adults smoked during pregnancy.
• The results of this study provide robust evidence that maternal smoking in pregnancy is associated with changes in
DNA methylation that persist in the exposed offspring for many years after their prenatal exposure.
• These findings could have useful applications in epidemiological studies, e.g. by using DNA methylation signatures
as a biosocial archive for exposure when data on maternal smoking during pregnancy are absent.
2 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy091/5026413
by University Library user
on 11 July 2018
participants. Ethical approval for the study was obtained
from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees.
We examined offspring DNA methylation in relation to
reported maternal smoking during pregnancy in ALSPAC
using methylation data from the Illumina Infinium
HumanMethylation450 (HM450) BeadChip assay
(Illumina, San Diego, CA, USA). We used data from
women enrolled ALSPAC (n¼ 754) in the main analysis
and looked to replicate findings in the same women ap-
proximately 18 years later (n¼ 656) and in men enrolled in
ALSPAC (n¼ 230).
Prenatal exposure variables
After recruitment of pregnant women into the ALSPAC
study, information was collected on both the women and
their partners, including details of their mothers’ smoking
behaviour. If the men and women reported that their
mothers had smoked, they were asked whether their moth-
ers had smoked when they were pregnant with them and
were given the responses yes/no/don’t know from which to
select. These data were analysed assuming that, for all
those who said don’t know, their mothers did smoke dur-
ing pregnancy, as has been done previously.20 We carried
out further sensitivity analysis excluding those individuals
who were unsure of their mothers’ smoking status during
pregnancy and compared findings.
DNA methylation assessment
We examined offspring DNA methylation in peripheral
blood in ALSPAC men and women. As part of the
Accessible Resource for Integrated Epigenomics Studies
(ARIES) project,21 the HM450 BeadChip22 has been used
to generate epigenetic data on 1018 mother–offspring pairs
in the ALSPAC cohort. A web portal has been constructed
to allow openly accessible browsing of aggregate ARIES
DNA methylation data (ARIES-Explorer) (http://www.arie
sepigenomics.org.uk/). Additional HM450 data have been
generated on ALSPAC men (the partners of the women en-
rolled in ARIES) (n¼ 312). Details of sample handling and
DNA methylation profiling are outlined in the
Supplementary Material, available as Supplementary data
at IJE online.
Covariates
Maternal age at birth and head of household social class
were included as covariates in these analyses, as they were
found to be most strongly associated with smoking status
during pregnancy in a previous study.4 In addition, 10
surrogate variables and cell count fractions were included
as additional covariates to adjust for technical batch and
cell-type mixture (see Supplementary Material, available as
Supplementary data at IJE online, for further details), al-
though we did not find strong evidence for associations be-
tween prenatal smoke exposure and derived cell types
(Supplementary Table 1, available as Supplementary data
at IJE online).
In order to evaluate the potential influence of own
smoking, which might explain the persistence in methyla-
tion signatures associated with intrauterine exposure, in-
formation on the ALSPAC women’s own smoking status
was obtained from a questionnaire administered at 18
weeks’ gestation. Women were asked whether they had
smoked regularly pre-pregnancy, from which a dichoto-
mous variable for any tobacco smoking before pregnancy
was derived. To assess the impact of passive smoke expo-
sure, women were also asked whether their partners
smoked at the same time point and whether their fathers
(as well as their mothers) had smoked previously.
For the replication analysis, information on the wom-
en’s smoking status was also gathered in a questionnaire
administered approximately 18 years later. Furthermore,
information on the partner’s smoking status was obtained
from a questionnaire administered to the partners approxi-
mately 21 years after the pregnancy. At these later time
points, the men and women were asked whether they cur-
rently smoked or whether they had smoked every day
when a smoker in the past. From these data, a dichoto-
mous variable for any previous tobacco smoking was
derived.
Statistical analysis
We first performed an epigenome-wide association analysis
in our largest sample: the ALSPAC women with methyla-
tion measured in peripheral blood taken at the time of en-
rolment in the study (n¼ 754). CpG level methylation
[untransformed b-values, which is the ratio of the methyl-
ated probe intensity and the overall intensity and ranges
from 0 (no cytosine methylation) to 1 (complete cytosine
methylation)] was regressed against prenatal smoke expo-
sure (any maternal smoking during pregnancy) with adjust-
ment for covariates (maternal age, parental social class,
offspring age, top 10 SVs in the main model). We then
assessed whether associations were robust to adjustment
for own smoking status (including own smoking status as a
further covariate and also running the EWAS stratified by
own smoking status) and passive smoke exposure
(reported partner smoking).
To evaluate the specificity of the intrauterine effect and
potential bias in our findings due to the role of passive
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smoke exposure out of pregnancy or residual confounding,
we conducted two negative control tests23–25: (i) perform-
ing a comparison of the associations between parental
smoking (any paternal smoking and any maternal smok-
ing) and methylation levels at the top CpG sites and (ii)
comparing associations between maternal smoking outside
of pregnancy and methylation levels with maternal smok-
ing during pregnancy and methylation levels at the same
sites.
We next performed replication analyses for the top
CpG sites [false discovery rate (FDR)< 0.05] in the other
samples, by conducting EWAS of maternal smoking in the
ALSPAC women 18 years later and ALSPAC men, adjusted
for the same covariates as in the main model for the
ALSPAC women at enrolment, and performing a look-up
of the CpGs identified in the main analysis. We also
assessed the association between prenatal smoke exposure
and methylation at the identified sites in cord blood in the
ALSPAC cohort that has been investigated previously3,4
(Supplementary Table 2, available as Supplementary data
at IJE online). We next performed Pearson’s correlation
analysis in order to compare consistency in effect estimates
between the main analysis and the replication analysis.
We also investigated the association between prenatal
exposure to smoking and DNA methylation for the 568
CpG sites previously found to be robustly associated with
prenatal smoke in a cord blood meta-analysis at
Bonferroni significance (n¼ 6685),3 in each of the adult
cohorts. We assessed the degree of inflation of association
signal (lambda value) for these CpG sites compared with
that seen genome-wide across the samples and performed a
Wilcoxon rank sum test to assess enrichment.
Furthermore, we generated a DNA methylation score26
for prenatal smoking based on these independently identi-
fied 568 CpG sites and compared its ability to predict
whether the mothers of the ALSPAC adults had smoked
during pregnancy with a score based on 19 CpG sites that
reached Bonferroni significance in an EWAS of prenatal
smoking conducted in peripheral blood of older children
(n¼ 3187)3 and a score for own smoking, consisting of
2623 CpG sites that reached Bonferroni significance in the
largest EWAS of own smoking to date (n¼ 9389 current vs
never smokers).27 Details of these studies and how the
scores were generated are outlined in Supplementary Table
2, available as Supplementary data at IJE online, and the
Supplementary Material, available as Supplementary data
at IJE online.
We generated receiver operating characteristic (ROC)
curves for the prenatal and own smoking methylation
scores and calculated the area under the curve (AUC) in or-
der to assess the performance of these predictors using the
pROC package in R. Given the overlap of CpG sites
associated with both prenatal smoking and own smoking
(Supplementary Figure 1, available as Supplementary data
at IJE online), we also assessed the performance of the pre-
natal smoking score adjusted for the own smoking score.
We compared the AUC of pairs of ROC curves using the
Delong test for difference computed by the roc.test func-
tion as part of the pROC package.
We also investigated the extent to which the prenatal
smoking scores could predict maternal smoking in preg-
nancy independently of own smoking status. This was
done by comparing methylation scores between four differ-
ent groups of participants, determined based on their own
smoking status and that of their mothers during pregnancy:
non-smokers whose mothers never smoked in pregnancy,
smokers whose mothers never smoked in pregnancy, non-
smokers whose mothers smoked in pregnancy and smokers
whose mothers smoked in pregnancy. Pairwise compari-
sons between the groups were performed using two-tailed
t-tests and a p-value for difference in methylation scores
obtained. In addition, a p-value for trend was obtained
from the linear regression of the methylation score on
smoking status, where the four groups were included in an
ordered categorical variable.
Analysis was performed using Stata (version 14) and R
(version 3.3.1).
Results
The cohort-specific summary statistics for this analysis are
presented in Table 1. The ALSPAC women in our main
analysis had a mean age of 30 years, whereas their mean
age at follow-up was 48 years and the ALSPAC men had a
mean age of 53 years. Maternal ages at birth were similar
between the ALSPAC men and women, as were parental
social class and rates of prenatal smoke exposure. Rates of
own smoking varied quite substantially, from 16.9% in the
ALSPAC women at the first time point to 33.8% in the
ALSPAC men. There was limited evidence for an associa-
tion between prenatal smoke exposure and own smoking
in the three study groups (Supplementary Table 3, avail-
able as Supplementary data at IJE online).
We observed associations between 15 CpG sites and
prenatal smoking exposure in women at age 30 at
FDR< 5% and 9 CpG sites that surpassed Bonferroni cor-
rection (Table 2). These sites were located in 11 gene
regions and all but 2 have been previously identified in
EWAS for maternal smoking at birth3 and into later
life3,4,6,10–12,17 and all agree on direction of effect
(Supplementary Table 4, available as Supplementary data
at IJE online).
Associations at CpG sites located near ARL4C
(cg05204104 and cg15016771), MDM4 (cg08241939)
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and DRD1 (cg22807681) appear to be novel, although the
sites at ARL4C were present in the extended list of FDR
significant sites in the previous cord blood EWAS.3 In con-
trast to findings in cord blood, where smoking during preg-
nancy has been associated approximately equally with
hyper and hypomethylation,3 the majority (14 out of 15
CpGs) showed long-term hypermethylation in this
analysis.
Whereas, in most EWAS for cord blood methylation,
AHRR (cg05575921) is the CpG site most consistently as-
sociated with prenatal smoke exposure,3,4,28,29 this site did
not survive adjustment for multiple tests in our persistence
analysis (p¼ 0.0005, FDR>5%). Rather, associations at
four sites at MYO1G (cg22132788, cg12803068,
cg04180046 and cg19089201) did survive multiple testing
adjustment, with the MYO1G site cg22132788 having the
strongest association (P¼ 1.710–13), which is consistent
with findings in children and adolescents.4,6,12
Results were robust to the additional inclusion of de-
rived cell counts as covariates, with 14 of the 15 CpG sites
surpassing the FDR< 5% threshold and the other CpG
site at DRD1 (cg22807681) with p¼ 5.22 10–6
(Supplementary Table 5, available as Supplementary data
at IJE online). In sensitivity analysis where those partici-
pants who were unsure of their mothers’ smoking status
during pregnancy were removed (n¼ 651 remained in the
Table 1. Descriptive characteristics of participant groups in this study
ALSPAC adult females
(Time Point 1)
ALSPAC adult females
(Time Point 2)
ALSPAC
adult males
N 754 656 230
Maternal age at birth (years) (SD) 27.6 (5.7) 27.8 (5.7) 28.2 (5.7)
Social class (manual) (N, %) 347 (46.0) 301 (45.9) 92 (40.0)
Prenatal smoke exposure (yes) (N, %) 216 (28.7) 179 (27.3) 73 (31.7)
Age at follow-up (years) (SD) 30.3 (4.3) 48.1 (4.2) 53.4 (5.1)
Sample type(s) Whole blood/white cells White cells/PBLs White cells/PBLs
Own smoking (N, %)a 127 (16.9) 144 (28.9) 75 (33.8)
aThe sample size of individuals who reported own smoking was slightly smaller with N¼ 752, N¼ 498 and N¼ 222 for ALSPAC adult females (Time Point 1),
ALSPAC adult females (Time Point 2) and ALSPAC adult males (Time Point 3), respectively.
Table 2. DNA methylation changes associated with prenatal smoke exposure in ALSPAC women (Time Point 1)
CpG site Chromosome Gene
region
Position Basic model (N¼754a) Adjusted modelb (N¼752)
Effect
size
Standard
error
P-value FDR Effect
size
Standard
error
P-value FDR
cg22132788 7 MYO1G 45002486 0.062 0.008 1.70E-13 8.26E-08 0.058 0.008 9.77E-13 4.75E-07
cg12803068 7 MYO1G 45002919 0.111 0.015 9.82E-13 2.38E-07 0.097 0.014 1.71E-11 4.16E-06
cg11813497 10 FRMD4A 14372879 0.038 0.006 1.25E-10 2.02E-05 0.036 0.006 4.85E-10 7.85E-05
cg04180046 7 MYO1G 45002736 0.041 0.006 2.53E-10 3.07E-05 0.037 0.006 3.43E-09 3.33E-04
cg05549655 15 CYP1A1 75019143 0.007 0.001 1.21E-08 0.001 0.007 0.001 8.82E-10 1.07E-04
cg25949550 7 CNTNAP2 145814306 –0.005 0.001 1.48E-08 0.001 –0.004 0.001 2.41E-07 0.015
cg19089201 7 MYO1G 45002287 0.038 0.007 1.75E-08 0.001 0.034 0.007 1.88E-07 0.013
cg05204104 2 ARL4C 235403141 0.023 0.004 2.30E-08 0.001 0.023 0.004 4.12E-08 0.003
cg17924476 5 AHRR 323794 0.045 0.008 6.24E-08 0.003 0.040 0.008 5.33E-07 0.029
cg11429111 5 TIFAB 134813329 0.022 0.004 2.62E-07 0.013 0.019 0.004 2.90E-06 0.108
cg08241939 1 MDM4 204700816 0.022 0.004 5.04E-07 0.022 0.019 0.004 3.40E-06 0.110
cg11641006 2 AX748264 235213874 0.040 0.008 5.62E-07 0.023 0.029 0.006 1.27E-06 0.051
cg15016771 2 ARL4C 235403218 0.008 0.002 1.01E-06 0.036 0.007 0.002 3.35E-06 0.110
cg22807681 5 DRD1 174622933 0.023 0.005 1.04E-06 0.036 0.023 0.005 1.02E-06 0.045
cg26681628 16 FTO 54210550 0.037 0.008 1.27E-06 0.041 0.029 0.006 8.94E-06 0.193
Effect size¼ difference in methylation level (beta) between adult offspring of smokers and non-smokers in pregnancy.
Entries in bold represent sites that surpassed the Bonferroni threshold.
aN¼ 216 smoked during pregnancy, N¼ 538 no smoking during pregnancy.
bModel includes adjustment for own smoking.
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analysis, n¼ 103 were excluded), 12 CpG sites were found
to be associated with prenatal smoke exposure at
FDR< 5% in this smaller dataset (Supplementary Table 6,
available as Supplementary data at IJE online). Nine of
these CpG sites were overlapping with those in the main
analysis, with the remaining three CpG sites located in sim-
ilar gene regions [AHRR (cg05575921), TIFAB
(cg01952185) and FRMD4A (cg25464840)].
One concern related to the identification of these signals
is that they might reflect non-specific smoke exposure of
the offspring over the life course rather than a ‘critical pe-
riod’ effect of smoke exposure in utero.30 In particular, 11
out of the 15 CpGs have been identified in relation to cur-
rent vs never smoking status at FDR< 0.05 in a recent
EWAS of own smoking27 (Supplementary Table 4, avail-
able as Supplementary data at IJE online). To account for
this, we first examined whether past cigarette smoking by
the adult themselves influenced these associations by in-
cluding own smoking as a covariate in the model.
Adjustment for own smoking attenuated associations at
five CpG sites [TIFAB (cg11429111), MDM4
(cg08241939), AX748264 (cg11641006), ARL4C
(cg15016771) and FTO (cg26681628)] that no longer
reached the FDR cut-off for significance (Table 2 and
Figure 1), although, on the whole, the magnitude of effect
was only slightly reduced with this adjustment.
Furthermore, whereas methylation of CpG sites at
MYO1G, CNTNAP2 and AHRR have been consistently
identified in relation to own smoking, no such associations
have been found with CpG sites at FDRM4A, CYP1A1,
MDM4 or DRD1 in the largest EWAS of own smoking to
date.31 Findings were similar when analyses were stratified
by own smoking status, i.e. with consistent effect estimates
even among those women who had not previously smoked
regularly themselves (Supplementary Table 7, available as
Supplementary data at IJE online), although there was
some evidence for a difference in effect sizes between
smokers and non-smokers at ARL4C (cg05204104), where
the effect was larger among smokers than among non-
smokers (p for interaction¼ 0.001). Furthermore, results
were consistent when reported partner smoking was in-
cluded as a covariate as an indicator of passive smoke ex-
posure (Supplementary Table 8, available as
Supplementary data at IJE online).
For the negative control tests, the parental comparison
showed consistently larger effect estimates for maternal
smoking than for paternal smoking, although confidence
intervals overlapped for some of the sites [FRMD4A
(cg25464840), CYP1A1 (cg05549655), ARL4C
(cg05204104), AHRR (cg17924476) and MYO1G
(cg04180046)] (Supplementary Figure 2, available as
Supplementary data at IJE online). For the comparison of
associations between the offspring of women who smoked
during pregnancy and the offspring of women who smoked
outside of pregnancy, effect estimates were consistently
larger for those reporting maternal smoking during preg-
nancy, this time without overlapping confidence intervals
(Supplementary Figure 3, available as Supplementary data
at IJE online). Whereas, for MYO1G (cg12803066) and
MYO1G (cg22132766), there was some evidence of asso-
ciation between maternal smoking outside of pregnancy
with methylation levels, suggestive of either residual con-
founding in the intrauterine associations or a postnatal
smoking effect, these findings may also be explained by
misreporting of maternal smoking during pregnancy that
was based on retrospective reports by the offspring in
adulthood. This latter explanation is more likely given that
the paternal smoking estimates at these sites were consis-
tent with the null (Supplementary Figure 2, available as
Supplementary data at IJE online).
Effects at the top CpGs surpassing FDR correction in
the ALSPAC women were found to be consistent in direc-
tion although slightly attenuated in the follow-up analysis
approximately 18 years later (Pearson’s correlation coeffi-
cient, r¼ 0.92) (Figure 2 and Supplementary Figure 4,
available as Supplementary data at IJE online).
Furthermore, there was remarkable consistency in the di-
rection and magnitude of effects at these CpGs in blood
samples of the ALSPAC men (r¼0.77), with the exception
of DRD1, where effects were not as consistently replicated.
We also compared for reference the effect of any maternal
smoking on cord blood methylation in the ALSPAC birth
Figure 1. Manhattan plot for EWAS of prenatal smoke exposure in
ALSPAC women (Time Point 1)*. *N¼ 752, adjusted for own smoking.
Solid horizontal line represents Bonferroni threshold; dotted horizontal
line represents FDR correction (p< 0.05) threshold.
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Figure 2. Replication of CpG sites observed below FDR (p< 0.05) threshold in ALSPAC women at a later time point (Time Point 2) and in ALSPAC
men,* and comparison with effect of prenatal smoking on cord blood methylation in ALSPAC children. *Adjusted for own smoking in adult samples.
N¼ 860 ALSPAC cord blood (reference), N¼ 752 ALSPAC women (Time Point 1), N¼ 498 ALSPAC women (Time Point 2), N¼ 222 ALSPAC men.
Figure 3. Receiver operating characteristic (ROC) curves of prenatal and own smoking methylation scores for discriminating maternal smoking in
pregnancy. Total N¼ 922; NB: sample size in the main analysis is smaller due to inclusion of additional covariates into those models that were miss-
ing for some of the participants. Prenatal smoking methylation score (older children)¼ score derived from 19 CpG sites associated with maternal
smoking in older children in an independent study.3 Prenatal smoking methylation score (newborns)¼ score derived from 568 CpG sites associated
with maternal smoking in newborns in an independent study.3 Own smoking methylation score¼ score derived from 2623 CpG sites associated with
smoking status in adults in an independent study.31 Scores were applied to methylation data from ALSPAC adult females at Time Point 1.
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cohort at these CpGs and, again, both magnitude and di-
rection of effect were similar (r¼ 0.92) with the exception
of sites at ARL4C (cg05204104), AHRR (cg17924476)
and DRD4 (cg22807681). At these sites, the difference in
methylation was greater in the ALSPAC women than in
the newborns (Figure 2 and Supplementary Figure 4, avail-
able as Supplementary data at IJE online).
In addition, we found that, among women with a mean
age of 30 years (N¼ 754), there was a strong signal of as-
sociation above that expected by chance at CpG sites previ-
ously associated with prenatal smoke exposure in
newborns [lambda¼ 2.62 vs 1.14 for all CpG sites on the
Illumina Infinium HumanMethylation450 (HM450)
BeadChip; Wilcoxon rank sum test p-value< 2.2 10–16]
(Supplementary Figure 5, available as Supplementary data
at IJE online). Similarly, inflation of signals for prenatal
smoke exposure was seen in these women 18 years later
(lambda¼ 1.54, p-value¼ 5.6 10–15) and in the ALSPAC
men (lambda¼1.19, p-value¼ 2.2 10–4), compared with
all CpG sites on the HM450 BeadChip (Supplementary
Figure 5, available as Supplementary data at IJE online).
A prenatal smoking methylation score, derived by com-
bining methylation values at 568 CpG sites associated with
prenatal smoke exposure in cord blood of newborns in a
previous study,3 could predict whether the mothers of the
ALSPAC women smoked during pregnancy with an AUC
0.69 [95% confidence interval (CI) 0.67, 0.73]. This was
comparable with a score derived from 19 CpG sites previ-
ously associated with prenatal smoking in peripheral blood
of older children,3 which had an AUC 0.72 (95% CI 0.69,
0.76; P for difference¼ 0.97) (Figure 3).
To determine the extent to which methylation associa-
tions with prenatal smoking were different from own
smoking associations, we constructed a similar score de-
rived from 2623 CpG sites previously associated with own
smoking in adulthood.27 Whereas being strongly predictive
of own smoking status in the ALSPAC women (AUC 0.88,
95% CI 0.85, 0.91), this score was only weakly associated
with prenatal smoking compared with the 19-CpG prena-
tal smoking score (AUC 0.57, 95% CI 0.53, 0.61; P for dif-
ference¼ 3.0 10–11) (Figure 3). In addition, the 19-CpG
prenatal smoking methylation score was able to predict
with the same accuracy prenatal smoke exposure when ad-
justed for the offspring smoking methylation score (AUC
0.71, 95% CI 0.68, 0.75; P for difference¼ 0.06)
(Figure 3).
The prenatal smoking methylation scores were higher in
individuals (both smokers and non-smokers) exposed to
prenatal smoking compared with non-smokers who were
not exposed prenatally (i.e. the ‘OS.MS’ and ‘ONS.MS’
group vs the ‘ONS.MNS’ baseline group; p-value for
trend< 2.0 10–16) (Figure 4). The prenatal smoking
methylation score derived from 568 CpG sites identified in
newborns3 was not able to distinguish between non-
smokers whose mothers smoked in pregnancy compared
with smokers whose mothers did not smoke during preg-
nancy (difference in score between the ‘ONS.MS’ group
and the ‘OS.MNS’ group¼ –0.07, p¼ 0.61) (Figure 4a).
However, the score derived from 19 CpG sites which were
shown to persist in relation to prenatal smoke exposure
based on an EWAS in older children3 was higher in non-
smokers whose mothers smoked in pregnancy compared
Figure 4. Box plots to assess differences in prenatal smoking methylation scores. Prenatal smoking methylation score (newborns)¼ score
derived from 568 CpG sites associated with maternal smoking in newborns in an independent study.3 Prenatal smoking methylation score
(older children)¼ score derived from 19 CpG sites associated with maternal smoking in older children in an independent study.3 ONS,
MNS¼offspring non-smoker, mother never smoked in pregnancy (N¼ 522); OS, MNS¼offspring smoker, mother never smoked in pregnancy
(N¼ 112); ONS, MS¼offspring non-smoker, mother smoked in pregnancy (N¼222); OS, MS¼offspring smoker, mother smoked in pregnancy
(N¼ 66). NB: sample size in the main analysis is smaller due to inclusion of additional covariates into those models that were missing for some of the
participants.
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with smokers whose mothers did not smoke in pregnancy
(difference in score between the ‘ONS.MS’ group and the
‘OS.MNS’ group¼ 0.01, p¼ 0.001) (Figure 4b).
Discussion
In a large longitudinal cohort with genome-wide methyla-
tion data, we identified 15 CpG sites that were differen-
tially methylated in the peripheral blood of women over
30 years after exposure to prenatal smoking. Most of these
signals remained in sensitivity analyses adjusted for own
smoking and passive smoke exposure, and showed stron-
ger associations in relation to maternal smoke exposure in
pregnancy compared with smoke exposure outside of preg-
nancy (by both mothers and fathers) indicating specificity
of the intrauterine effect. Furthermore, we observed a per-
sistent methylation signal related to prenatal smoke expo-
sure in peripheral blood 18 years later (i.e. at around the
age of 48 years) and replicated in peripheral blood among
men in the ALSPAC cohort.
Many of these CpG sites have been previously identified
in relation to prenatal smoke exposure in the offspring at
birth3 and the majority showed long-term hypermethyla-
tion among the offspring of smokers. Findings are also
consistent with a recent report that highlighted persistence
of DNA methylation levels related to prenatal smoke expo-
sure into adulthood,17 which identified associations the
same CpG sites located in MYO1G and CYP1A1, and
other CpG sites in FTO and AHRR.
For all of the study samples, there was also a strong sig-
nal of association above that expected by chance at 568
CpG sites previously associated with prenatal smoke expo-
sure in newborns from an independent study.3 In addition,
we found that a prenatal smoking score, derived by com-
bining methylation values at these CpG sites, could ade-
quately predict whether the mothers of the adults in
ALSPAC smoked during pregnancy with an AUC 0.69
(95% CI 0.67, 0.73). A recent study identified a much
stronger predictive ability of a prenatal smoking methyla-
tion score with AUC of 0.90 in a test set of cord blood
obtained from newborns in the MoBa cohort.32 The differ-
ence in predictive ability is therefore likely attributed to the
30-year difference in time since exposure and the genera-
tion of this methylation score using CpG sites identified in
cord blood rather than adult peripheral blood. We also de-
rived a methylation score based on CpGs that showed evi-
dence of a persistent difference in methylation in
peripheral blood of older offspring exposed to prenatal
smoking3 who had a marginally higher AUC of 0.72 (95%
CI 0.67, 0.73) and was also able to distinguish non-
smokers whose mothers smoked in pregnancy from smok-
ers whose mothers did not smoke during pregnancy.
Strengths of our study include the large sample size of
women with reported maternal smoking in pregnancy for
performing our initial EWAS analysis, the ability to adjust
for own smoking status, the longitudinal assessment of dif-
ferential methylation in a follow-up sample of these
women and the replication analysis in men from the same
study.
Although there was evidence of persistence for methyla-
tion differences even after adjusting for own smoking sta-
tus in the adult offspring, there are limitations to
performing this type of adjustment analysis. As
parental smoking is strongly associated with their off-
spring’s smoking initiation,33 own smoking serves as a pos-
sible mediator on the path between prenatal smoking and
offspring DNA methylation. This method of adjusting for
a potential mediator in standard regression models to esti-
mate the direct effect of an exposure may produce spurious
conclusions.34,35 Whereas an alternative method of using
life-course models previously provided more evidence for
the hypothesis that maternal smoking in pregnancy is the
‘critical period’ for influencing persistent offspring methyl-
ation profiles,4 this method could not be applied here given
the limited amount of information on maternal smoking
reported by the ALSPAC men and women.
A further limitation relates to cell-type heterogeneity,
given that the ALSPAC samples were obtained from a vari-
ety of sources [white cells, whole blood and peripheral
blood lymphocytes (PBLs)]. To account for this, we incor-
porated surrogate variables into our models to account to
adjust for technical batch and cell-type mixture in order to
harmonize cellular variability of the samples36 and carried
out sensitivity analysis that also adjusted for derived cell
counts.37,38
In addition, information on prenatal smoke exposure in
the ALSPAC men and women was recorded retrospectively
by the adult offspring, rather than by prospective assess-
ment, and so may be subject to more misreporting.
Furthermore, in the ALSPAC men and women, rates of
maternal smoking in pregnancy were reported to be high
in comparison with contemporary populations. This draws
to question the relevance of identified associations.
However, we have shown that many of the signals identi-
fied in adults were also present in cord blood of offspring
measured prospectively in a more contemporary cohort
with lower rates of maternal smoking in pregnancy.4
Overall, the results of this study provide robust evidence
that maternal smoking in pregnancy is associated with
changes in DNA methylation that persist in the exposed
offspring for many years after their prenatal exposure.
Furthermore, these associations largely remain after adjust-
ing for the previous smoking history of the adults them-
selves and are in accordance with earlier studies
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investigating prospectively assessed maternal smoking dur-
ing pregnancy in relation to global DNA methylation
levels.14,15
Conclusion
These findings could have useful applications in epidemio-
logical studies, e.g. by using DNA methylation signatures
as a biosocial archive for historical exposure.5
Furthermore, persistent changes in DNA methylation
might mediate at least some of the associations between
smoke exposure in pregnancy and later-life health out-
comes.39 However, distinguishing mediation from other
association-driving mechanisms40 warrants further evalua-
tion with the integration of analytical techniques such as
two-step Mendelian randomization,41,42 transcriptomic
analysis and the profiling of target tissues.43
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